# ADCX-020 for the Treatment of Patients With Locally Advanced or Metastatic Cancers

Source: https://onco.cc/trials/nct07238075/  
OnCo record `nct07238075` (Trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

A phase 1 trial of ADCX-020 run by Adcytherix SAS, now recruiting.

## Summary

ADCX-020 for the Treatment of Patients With Locally Advanced or Metastatic Cancers is a phase 1 interventional study registered as NCT07238075 by Adcytherix SAS, with 290 participants planned, started 2026-02-23. Conditions recorded: Advanced Malignancy, Advanced Solid Cancers and Metastatic Solid Tumors. Interventions recorded: ADCX-020.

## Fields

- Kind: Trial
- Status: recruiting
- Last checked: 2026-11-03
- Tags: pipeline; ctgov-ingest
- Registry id: NCT07238075
- Phase: 1
- Setting: A First-in-human, Multicenter Dose Escalation and Multiple Cohort Expansion Phase 1a/b Study to Investigate Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of ADCX-020 in Participants With Locally Advanced or Metastatic Solid Tumors
- Sponsor: Adcytherix SAS
- Enrolled: 290

## Sources

- ClinicalTrials.gov NCT07238075: https://clinicaltrials.gov/study/NCT07238075

## Connected records

- cancers: [Metastatic cancer (cancer that has spread)](https://onco.cc/cancers/metastatic-cancer/)
- drugs: [ADCX-020](https://onco.cc/drugs/adcx-020/)
- companies: [Adcytherix](https://onco.cc/companies/adcytherix/)

---
JSON: https://onco.cc/api/v1/entities/nct07238075.json